[1]CurrentPatentAssignee:AGIOSPHARMACEUTICALSINC;SOLIDSTATEPHARMA-WO2019/104134,2019,A1Locationinpatent:Paragraph00173
[1]CurrentPatentAssignee:AGIOSPHARMACEUTICALSINC;SOLIDSTATEPHARMA-WO2019/104134,2019,A1Locationinpatent:Paragraph00203
[1]CurrentPatentAssignee:AGIOSPHARMACEUTICALSINC;SOLIDSTATEPHARMA-WO2019/104134,2019,A1
[1]CurrentPatentAssignee:AGIOSPHARMACEUTICALSINC;SOLIDSTATEPHARMA-WO2019/104134,2019,A1
Title: Kung C, et al. AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency. Blood. 2017;130(11):1347-1356.
Title: Rab MAE, et al. AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes. Haematologica. 2021;106(1):238-249.